Announcement.

MATRX PHARMACEUTICALS SA (4/2018) Termination of the contract for the function of Authorized Adviser

The Board of Matrx Pharmaceuticals S.A. with its registered office in Warsaw informs that today it received information about NWAI's termination of the Brokerage House S.A. with a registered office in Warsaw for the function of Authorized Adviser, which was announced by the current report No. 15/2017 dated September 21, 2017. The termination of the agreement took effect on March 30, 2018. Legal basis: § 3 . 1 point 9 of Appendix No. 3 to the Alternative Trading System Rules "Current and periodic information disclosed in the alternative trading system on the NewConnect market"

Automatic translation of the announcements.

Rate the announcements:


Positive

Neutral

Negative

ALL COMPANY ANNOUNCMENTS
Company information
Company name:Matrx Pharmaceuticals SA
ISIN:PLIBZIC00013
NIP:8971749035
Adress: Plac Powstańców Śląskich 1/201 53-329 Wrocław
Phone:+48 71 8811280
website:www.matrxpharmaceuticals.com

Copyright © 2017 PolandStockExchange
This website uses cookies (Regulations / Cookie Policy).